| PEQSX | VIVIX | PEQSX / VIVIX | |
| Total Expense Ratio | 0.52 | 0.03 | 1,733% |
| Annual Report Gross Expense Ratio | 0.52 | 0.03 | 1,733% |
| Fund Existence | 14 years | 28 years | - |
| Gain YTD | 12.457 | 14.777 | 84% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 5000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 54.1B | 254B | 21% |
| Annual Yield % from dividends | 1.20 | 1.88 | 64% |
| Returns for 1 year | 19.14 | 23.05 | 83% |
| Returns for 3 years | 52.54 | 53.89 | 97% |
| Returns for 5 years | 52.36 | 59.41 | 88% |
| Returns for 10 years | 145.69 | 151.57 | 96% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FSMEX | 48.10 | N/A | N/A |
| Fidelity Select Medical Tech and Devcs | |||
| WGMVX | 4.90 | N/A | N/A |
| Wasatch Micro Cap Value Institutional | |||
| AVDNX | 17.19 | N/A | N/A |
| Avantis® International Equity G | |||
| FEMAX | 15.44 | -0.18 | -1.15% |
| First Eagle U.S. SMID Cap Opportunity A | |||
| CGVHX | 30.80 | -0.41 | -1.31% |
| American Funds Global Insight 529-F-3 | |||